Department of Cardiology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310053, China.
Department of Pathology and Pathophysiology, Zhejiang University School of Medicine, Hangzhou 310058, China.
J Ethnopharmacol. 2019 Mar 1;231:507-515. doi: 10.1016/j.jep.2018.11.043. Epub 2018 Nov 30.
The concept of the prescription in Traditional Chinese Medicine (TCM) is usually characterized by the compatibility principle "monarch, minister, assistant, and guide", which means herbs play primary, secondary, auxiliary, or harmonic roles, respectively, to achieve the optimally holistic effect. Following this compatibility principle, the Tanyu Tongzhi Formula (TTF), used for many years to treat cardiovascular diseases, has been proved effective clinically and experimentally.
The ancient compatibility principle is based on experiences, but whether its underlying interactions can be explained at the cellular level is unknown. We aimed to explore the mechanisms of activity of the TTF herbs and the interactions between them.
We used a real-time cell analyzer to record the responses of COS-7 cells to the herbs in TTF, both individually and in different combinations. We also used biochemical assays to further characterize the TTF activity.
Monarch herb Fructus trichosanthis acts as an inhibitor of the EGF signaling. It's cytotoxicity, derived from inhibition of tubulin polymerization, could be completely neutralized by the combination of the phlegm group, or the whole TTF combination. Meanwhile, the minister, assistant, and guide herbs in the TTF did not affect EGF signaling.
Our results provide a demonstration, at the cellular level, of the compatibility principle of "monarch, minister, assistant, and guide" in TTF. Under the guidance of this principle, TTF exerts the anti-inflammation and anti-tumor effects through inhibiting EGF signaling, while avoiding the microtubule-disrupting activity of Fructus trichosanthis.
中医(TCM)处方的概念通常以“君、臣、佐、使”的配伍原则为特征,这意味着草药分别发挥主要、次要、辅助或调和作用,以达到最佳的整体效果。根据这一配伍原则,多年来用于治疗心血管疾病的痰瘀同治方(TTF)已在临床和实验中得到证实有效。
古代的配伍原则是基于经验,但它的潜在相互作用是否可以在细胞水平上解释尚不清楚。我们旨在探讨 TTF 草药的活性机制及其相互作用。
我们使用实时细胞分析仪记录 COS-7 细胞对 TTF 中草药的单独和不同组合的反应。我们还使用生化测定进一步表征 TTF 的活性。
君药瓜蒌仁作为 EGF 信号的抑制剂。它的细胞毒性,来源于对微管聚合的抑制,可通过痰组或整个 TTF 组合完全中和。同时,TTF 中的臣药、佐药和使药并不影响 EGF 信号。
我们的结果在细胞水平上证明了 TTF 中“君、臣、佐、使”的配伍原则。在这一原则的指导下,TTF 通过抑制 EGF 信号发挥抗炎和抗肿瘤作用,同时避免瓜蒌仁的微管破坏活性。